Protagonist Therapeutics Inc (PTGX) Stock Price, Quote, News & History

PTGXNASDAQ
$102.79
7.387.74%
At close: Jun 4, 5:00 PM EST
$103.42
0.630.61%
After Hours: 4:38 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-116.64M
Investing Cash Flow (TTM)
135.96M
Financing Cash Flow (TTM)
34.80M
Free Cash Flow (TTM)
-117.90M
Capital Expenditure (TTM)
-1.26M
Net Change in Cash (TTM)
54.12M

Analyst Trends and Forecast

3
Feb
4
1
Mar
2
Apr
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$5.56B
PE Ratio (TTM)
-
PE Ratio (FWD)
21.79
PEG Ratio (TTM)
-
PS Ratio (TTM)
90.95
PB Ratio (TTM)
10.10
Earnings Yield % (TTM)
-1.76%
Earnings Yield % (FWD)
4.59%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$10.19

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$193.71M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$96.39
Close
$102.79
Volume / Avg.
658.83K / 728.11K
Day Range
$96.14 - $103.55
52 Wk Range
49.38 - 107.84
Market Cap
$6.65B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
63
Short Interest
13.19%
Days to Cover
12.76

About

Sector
Health Care
Industry
Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology,...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Protagonist Therapeutics (PTGX) stock?

A

You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Protagonist Therapeutics (PTGX) competitors?

A

There are no as such competitors for Protagonist Therapeutics.

Q

What is the forecast, or price target, for Protagonist Therapeutics (PTGX) stock?

A

Protagonist Therapeutics has a consensus price target of $96.61.

Q

What is the current price for Protagonist Therapeutics (PTGX)?

A

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $103.4153 last updated June 4, 2026 at 4:38 PM EDT.

Q

Does Protagonist Therapeutics (PTGX) pay a dividend?

A

There are no upcoming dividends for Protagonist Therapeutics.

Q

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

A

Protagonist Therapeutics does not have any upcoming earnings scheduled.

Q

Is Protagonist Therapeutics (PTGX) going to split?

A

There is no upcoming split for Protagonist Therapeutics.

Q

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

A

Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.